AccelDx’s technology enables patients and healthcare providers to perform lab-quality medical diagnostic tests at any time and anywhere. The patented pScreen™ platform technology employs a single-use blood test the size of a credit card in tandem with a smartphone application to quickly detect disease-specific biomarker levels. The app can then analyze and transfer the results to the patient’s healthcare provider immediately.
AccelDx’s initial product targets Heart Failure (HF) patients. Re-hospitalization of HF patients has become a $20+ billion problem. With the pScreen™ system, patients can – for the first time ever – monitor their heart conditions at home, and send via smarthphone to their healthcare providers up-to-date information on current, historical, and trending HF biomarker BNP (natriuretic peptide) levels. This allows healthcare providers and physicians to monitor heart distress levels and prevent HF-related life threatening events and costly re-hospitalizations.